薬物スクリーニング市場

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2022年01月

薬物スクリーニング市場:製品(消耗品、尿検査装置、分析、飲酒、クロマトグラフィー、イムノアッセイ)サービス、サンプルタイプ(尿、呼気)、エンドユーザー(職場、研究所、刑事司法、病院)- 2026年までの世界予測

Drug Screening Market by Product (Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) – Global Forecast to 2026

ページ数215
図表数243
種別英文調査報告書
価格

レポート目次    見積ご依頼・お問合せ    ご購入案内

無料サンプル

The global drug screening market is projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period. Market growth can be largely attributed to the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing, rising regulatory approvals for drug screening products & services. On the other hand, bans on alcohol consumption in Islamic countries and prohibitions on workplace drug testing in specific countries may hinder the growth of this market to a certain extent.

“Drug screening services are expected to grow at the highest CAGR during the forecast period”
Drug screening market is segmented into products and services. In 2020,the services segment is expected to hold the largest share 57.4% of the drug screening market, growth in this segment is attributed to factors such growing drug & alcohol consumption worldwide, funding initiatives for drug testing laboratories, service launches and regulatory approvals, and geographic expansion of drug testing laboratories.

By sample type, urine samples are expected to dominate the market during the forecast period”
The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to hold the largest share 61.5% of the drug screening market in 2020 due to the benefits it offers such as easy collection method, high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

“North America will dominate the market during the forecast period.”
Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2020, North America accounted for the largest share of 48.2% of the drug screening marke tfollowed by Europe. However, Asia Pacific is expected to register the highest CAGR 19.6% during the forecast period. The high growth of this regional segment is attributed due to the growing illicit consumption of drugs, the developing healthcare infrastructure and rising adoption of stringent regulatory guidelines for drug testing.
The primary interviews conducted for this report can be categorized as follows:
•By Company Type -Tier 1: 57%, Tier 2: 30%,and Tier 3: 13%
•By Designation – C-level:30%, D-level:45%, and Others:25%
•By Region – North America:40%, Europe:19%, Asia Pacific:29%, and Rest of the World: 12%

Some of the prominent players operating in the drug screening market are LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), OraSure Technologies (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Drägerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), and Siemens Healthineers (Germany).

Research Coverage:
This report provides a detailed picture of the global drug screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product and service, sample type, end user,and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total drug screening market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
•Market Penetration: Comprehensive information on drug screening offered by the top 25 players in the drug screening market. The report analyses the drug screening market by product and service, sample type, end user, and region.

•Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various drug screening across key geographic regions.

•Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening market.

•Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the drug screening market.


目次

1INTRODUCTION31
1.1OBJECTIVES OF THE STUDY31
1.2MARKET DEFINITION31
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY32
1.3MARKET SCOPE33
1.3.1MARKETS COVERED33
1.3.2YEARS CONSIDERED FOR THE STUDY34
1.4CURRENCY34
1.5LIMITATIONS34
1.6MARKET STAKEHOLDERS34
1.7SUMMARY OF CHANGES35
2RESEARCH METHODOLOGY36
2.1RESEARCH DATA36
FIGURE 1RESEARCH DESIGN36
2.1.1SECONDARY DATA37
2.1.1.1Key data from secondary sources38
2.1.2PRIMARY DATA38
FIGURE 2PRIMARY SOURCES39
2.1.2.1Key industry insights40
2.1.2.2Breakdown of primary interviews40
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION,
AND REGION40
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER
AND REGION41
2.2MARKET SIZE ESTIMATION41
2.2.1TOTAL MARKET SIZE: DRUG SCREENING MARKET41
FIGURE 5SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS42
FIGURE 6BOTTOM-UP APPROACH: NO OF TESTING VOLUME BASED ESTIMATION43
2.2.2TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION45
FIGURE 7DRUG SCREENING MARKET: TOP-DOWN APPROACH45
2.2.3GROWTH FORECAST45
FIGURE 8CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE DRUG SCREENING MARKET (2021–2026)46
FIGURE 9CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS46
2.3MARKET BREAKDOWN & DATA TRIANGULATION47
FIGURE 10DATA TRIANGULATION METHODOLOGY47
2.4ASSUMPTIONS FOR THE STUDY48
2.5RISK ASSESSMENT48
TABLE 1RISK ASSESSMENT: DRUG SCREENING MARKET48
2.6LIMITATIONS48
3EXECUTIVE SUMMARY49
FIGURE 11DRUG SCREENING SERVICES MARKET TO RECORD THE HIGHEST CAGR DURING THE FORECAST PERIOD49
FIGURE 12ANALYTICAL INSTRUMENTS SEGMENT TO DOMINATE THE DRUG SCREENING PRODUCTS MARKET, 2021–2026 (USD MILLION)50
FIGURE 13DRUG TESTING LABORATORIES ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET DURING THE FORECAST PERIOD (USD MILLION)50
FIGURE 14GEOGRAPHIC SNAPSHOT OF THE DRUG SCREENING MARKET51
4PREMIUM INSIGHTS52
4.1DRUG SCREENING MARKET OVERVIEW52
FIGURE 15GROWING CONSUMPTION OF ILLICIT DRUGS AND ALCOHOL TO DRIVE MARKET GROWTH52
4.2DRUG SCREENING MARKET, BY PRODUCT & SERVICE52
FIGURE 16SERVICES SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (USD MILLION)52
4.3DRUG SCREENING MARKET, BY SAMPLE TYPE53
FIGURE 17ORAL FLUID SAMPLES SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (USD MILLION)53
4.4DRUG SCREENING MARKET: GEOGRAPHIC SNAPSHOT53
FIGURE 18INDIA TO WITNESS THE HIGHEST GROWTH RATE IN THE DRUG SCREENING MARKET DURING THE FORECAST PERIOD53
5MARKET OVERVIEW54
5.1INTRODUCTION54
5.2MARKET DYNAMICS54
FIGURE 19DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES54
5.2.1DRIVERS55
5.2.1.1Growing drug & alcohol consumption55
5.2.1.2Enforcement of stringent laws mandating drug & alcohol testing55
5.2.1.3Rising regulatory approvals for drug screening products & services56
TABLE 2KEY PRODUCT & SERVICE LAUNCHES (2018–2021)56
TABLE 3RECENT APPROVALS FOR DRUG & ALCOHOL TESTING PRODUCTS & SERVICES56
5.2.2RESTRAINTS57
5.2.2.1Ban on alcohol consumption in several Islamic countries57
5.2.2.2Prohibition on workplace drug testing in specific countries57
5.2.3OPPORTUNITIES57
5.2.3.1Oral fluid testing57
5.2.3.2Fingerprint-based drug testing57
5.2.3.3Emerging economies58
5.2.4CHALLENGES58
5.2.4.1Accuracy and specificity concerns related to breathalyzers58
5.3VALUE CHAIN ANALYSIS59
FIGURE 20DRUG SCREENING MARKET: VALUE CHAIN ANALYSIS59
5.4ECOSYSTEM ANALYSIS60
FIGURE 21ECOSYSTEM: DRUG SCREENING MARKET60
TABLE 4ROLE OF MARKET PLAYERS IN THE DRUG SCREENING ECOSYSTEM61
5.5IMPACT OF COVID 19 ON DRUG SCREENING MARKET61
5.6PORTER’S FIVE FORCES ANALYSIS62
TABLE 5DRUG SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS62
5.6.1DEGREE OF COMPETITION62
5.6.2BARGAINING POWER OF SUPPLIERS62
5.6.3BARGAINING POWER OF BUYERS63
5.6.4THREAT OF SUBSTITUTES63
5.6.5THREAT OF NEW ENTRANTS63
5.7TECHNOLOGY ANALYSIS63
5.8REGULATORY ANALYSIS64
5.8.1REGULATORY ASPECTS OF WORKPLACE DRUG TESTING64
5.8.1.1US64
5.8.1.1.1Substance Abuse and Mental Health Services Administration (SAMSHA)64
5.8.1.1.1.1Federal workplace drug testing64
5.8.1.1.1.2Federal laws and regulations64
5.8.1.1.2Department of Transportation (DOT)65
TABLE 6US: DRUG AND ALCOHOL TESTING REGULATIONS66
5.8.1.2Europe66
5.8.1.2.1Finland66
5.8.1.2.2Sweden66
5.8.1.2.3France66
5.8.1.2.4Italy67
5.8.1.2.5United Kingdom67
5.8.1.2.6Netherlands67
5.8.1.2.7Ireland67
5.8.1.3Australia and New Zealand67
5.9PATENT ANALYSIS68
5.10CASE STUDY ANALYSIS69
5.10.1LEADING RETAIL CHAIN SAVES $1 MILLION WITH INSTANT ORAL FLUID EMPLOYEE DRUG SCREEN SOLUTION69
5.10.2A BETTER AND INCREASINGLY EFFICIENT DRUG SCREENING SYSTEM69
5.10.3PRE-EMPLOYMENT TESTING-LONG TERM CARE INDUSTRY69
5.10.4HAIR TESTING VS. URINALYSIS (TRANSPORTATION INDUSTRY)70
5.10.5RANDOM TESTING (MANUFACTURING/AUTOMOTIVE)70
5.10.6CONTRACTOR TESTING (OIL/GAS)70
5.10.7KINGS TRANSPORT-DRUG AND ALCOHOL TESTING71
6DRUG SCREENING MARKET, BY PRODUCT & SERVICE72
6.1INTRODUCTION73
TABLE 7DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)73
6.2DRUG SCREENING SERVICES73
6.2.1ADVANCED DRUG SCREENING TESTS & SERVICES TO DRIVE THE GROWTH OF THIS SEGMENT73
TABLE 8DRUG SCREENING SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION)74
6.3DRUG SCREENING PRODUCTS74
TABLE 9DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019–2026 (USD MILLION)74
6.3.1ANALYTICAL INSTRUMENTS74
TABLE 10DRUG SCREENING PRODUCT MARKET FOR ANALYTICAL INSTRUMENTS,
BY TYPE, 2019–2026 (USD MILLION)75
TABLE 11DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS,
BY REGION, 2019–2026 (USD MILLION)75
6.3.1.1Breathalyzers75
6.3.1.1.1Law enforcement agencies widely use breathalyzers75
TABLE 12BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)76
TABLE 13BREATHALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)76
6.3.1.1.2Fuel-cell breathalyzers76
TABLE 14FUEL-CELL BREATHALYZERS MARKET, BY REGION,
2019–2026 (USD MILLION)77
6.3.1.1.3Semiconductor breathalyzers77
TABLE 15SEMICONDUCTOR BREATHALYZERS MARKET, BY REGION,
2019–2026 (USD MILLION)77
6.3.1.1.4Other breathalyzers77
TABLE 16OTHER BREATHALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)78
6.3.1.2Immunoassay analyzers78
6.3.1.2.1North America is the largest market for immunoassay analyzers78
TABLE 17IMMUNOASSAY ANALYZERS MARKET, BY REGION,
2019–2026 (USD MILLION)79
6.3.1.3Chromatography instruments79
6.3.1.3.1Chromatography techniques show higher accuracy than immunoassays79
TABLE 18CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION)79
6.3.2RAPID TESTING DEVICES80
TABLE 19DRUG SCREENING PRODUCT MARKET FOR RAPID TESTING DEVICES,
BY TYPE, 2019–2026 (USD MILLION)80
TABLE 20DRUG SCREENING PRODUCT MARKET FOR RAPID TESTING DEVICES,
BY REGION, 2019–2026 (USD MILLION)80
6.3.2.1Urine testing devices80
6.3.2.1.1Urine testing provides results within minutes and is used in a wide range of applications80
TABLE 21URINE TESTING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)81
TABLE 22URINE TESTING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)81
6.3.2.1.2Drug testing cups81
TABLE 23DRUG TESTING CUPS MARKET, BY REGION, 2019–2026 (USD MILLION)81
6.3.2.1.3Dip cards82
TABLE 24DIP CARDS MARKET, BY REGION, 2019–2026 (USD MILLION)82
6.3.2.1.4Drug testing cassettes82
TABLE 25DRUG TESTING CASSETTES MARKET, BY REGION,
2019–2026 (USD MILLION)82
6.3.2.2Oral fluid testing devices83
6.3.2.2.1Short detection windows, noninvasive nature, and low chance of sample tampering ensures the demand for oral fluid testing83
TABLE 26ORAL FLUID TESTING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION)83
6.3.3CONSUMABLES83
TABLE 27DRUG SCREENING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)83
TABLE 28DRUG SCREENING CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION)84
6.3.3.1Assay kits84
6.3.3.1.1Immunoassay kits provide a rapid and inexpensive method to screen samples84
TABLE 29ASSAY KITS MARKET, BY REGION, 2019–2026 (USD MILLION)84
6.3.3.2Sample collection devices85
6.3.3.2.1Sample collection devices see wide usage in drug testing laboratories85
TABLE 30SAMPLE COLLECTION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION)85
6.3.3.3Calibrators & controls85
TABLE 31CALIBRATORS & CONTROLS MARKET, BY REGION,
2019–2026 (USD MILLION)86
6.3.3.4Other consumables86
TABLE 32OTHER CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)86
7DRUG SCREENING MARKET, BY SAMPLE TYPE87
7.1INTRODUCTION88
TABLE 33DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019–2026 (USD MILLION)88
7.2URINE SAMPLES88
7.2.1EASE OF COLLECTION AND NONINVASIVENESS HAS SUPPORTED THE USE OF URINE SAMPLES88
TABLE 34DRUG SCREENING MARKET FOR URINE SAMPLES, BY REGION,
2019–2026 (USD MILLION)89
7.3BREATH SAMPLES89
7.3.1BREATH ALCOHOL TESTS SEE WIDE USAGE IN WORKPLACE TESTING AND LAW ENFORCEMENT APPLICATIONS89
TABLE 35DRUG SCREENING MARKET FOR BREATH SAMPLES, BY REGION,
2019–2026 (USD MILLION)89
7.4ORAL FLUID SAMPLES90
7.4.1NONINVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION HAVE SUPPORTED THE USAGE OF ORAL FLUID SAMPLES90
TABLE 36DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY REGION,
2019–2026 (USD MILLION)90
7.5HAIR SAMPLES91
7.5.1HAIR SAMPLES CAN PROVIDE INSIGHTS INTO LONG-TERM DRUG USE91
TABLE 37DRUG SCREENING MARKET FOR HAIR SAMPLES, BY REGION,
2019–2026 (USD MILLION)91
7.6OTHER SAMPLES92
TABLE 38DRUG SCREENING MARKET FOR OTHER SAMPLES, BY REGION,
2019–2026 (USD MILLION)92
8DRUG SCREENING MARKET, BY END USER93
8.1INTRODUCTION94
TABLE 39DRUG SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)94
8.2DRUG TESTING LABORATORIES94
8.2.1DRUG TESTING LABORATORIES TO EXHIBIT THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD94
TABLE 40DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY REGION, 2019–2026 (USD MILLION)95
8.3WORKPLACES95
8.3.1THE RISING NUMBER OF DRUG ABUSE CASES HAS RESULTED IN AN INCREASE IN WORKPLACE TESTING95
TABLE 41DRUG SCREENING MARKET FOR WORKPLACES, BY REGION,
2019–2026 (USD MILLION)95
TABLE 42US: DRUG SCREENING MARKET, BY WORKPLACE TYPE,
2019–2026 (USD MILLION)96
8.4CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES96
8.4.1URINE IS THE MOST COMMONLY USED SAMPLE IN CRIMINAL JUSTICE SYSTEMS96
TABLE 43DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2019–2026 (USD MILLION)97
8.5HOSPITALS97
8.5.1RISING INCIDENCE OF DRUG ABUSE HAS RESULTED IN AN INCREASE IN EMERGENCY DEPARTMENT VISITS97
TABLE 44DRUG SCREENING MARKET FOR HOSPITALS, BY REGION,
2019–2026 (USD MILLION)97
8.6DRUG TREATMENT CENTERS98
8.6.1AVAILABILITY OF GOVERNMENT SUPPORT IS A KEY GROWTH DRIVER FOR REHABILITATION CENTERS98
TABLE 45DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY REGION, 2019–2026 (USD MILLION)98
8.7INDIVIDUAL USERS98
8.7.1PERSONAL BREATHALYZERS ARE WITNESSING INCREASING ADOPTION DUE TO STRINGENT DUI REGULATIONS98
TABLE 46DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY REGION,
2019–2026 (USD MILLION)99
8.8PAIN MANAGEMENT CENTERS99
8.8.1RISING SUBSTANCE ABUSE HAS SUPPORTED DRUG TESTING IN PAIN MANAGEMENT APPLICATIONS99
TABLE 47DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY REGION, 2019–2026 (USD MILLION)100
8.9SCHOOLS AND COLLEGES100
8.9.1DRUG ABUSE TESTING PROGRAMS HAVE BEEN INTRODUCED IN SCHOOLS TO CURB DRUG ABUSE100
TABLE 48DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY REGION, 2019–2026 (USD MILLION)100
9DRUG SCREENING MARKET, BY REGION101
9.1INTRODUCTION102
TABLE 49DRUG SCREENING MARKET, BY REGION, 2019–2026 (USD MILLION)102
9.2NORTH AMERICA103
FIGURE 22NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT103
TABLE 50NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY,
2019–2026 (USD MILLION)104
TABLE 51NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)104
TABLE 52NORTH AMERICA: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)104
TABLE 53NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)105
TABLE 54NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE,
2019–2026 (USD MILLION)105
TABLE 55NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)105
TABLE 56NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)106
TABLE 57NORTH AMERICA: CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION)106
TABLE 58NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)106
TABLE 59NORTH AMERICA: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)107
9.2.1US107
9.2.1.1The US holds the largest share of the drug screening market
in North America107
TABLE 60US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)108
TABLE 61US: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)108
TABLE 62US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)109
TABLE 63US: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)109
TABLE 64US: RAPID TESTING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)109
TABLE 65US: URINE TESTING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)109
TABLE 66US: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)110
TABLE 67US: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)110
TABLE 68US: DRUG SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)110
9.2.2CANADA111
9.2.2.1The high rate of DUI-related accidental deaths is expected to drive the use of breathalyzers in this market111
TABLE 69CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)112
TABLE 70CANADA: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)112
TABLE 71CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)112
TABLE 72CANADA: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)113
TABLE 73CANADA: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)113
TABLE 74CANADA: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)113
TABLE 75CANADA: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)114
TABLE 76CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)114
TABLE 77CANADA: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)114
9.3EUROPE115
TABLE 78EUROPE: DRUG SCREENING MARKET, BY COUNTRY,
2019–2026 (USD MILLION)115
TABLE 79EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)115
TABLE 80EUROPE: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)116
TABLE 81EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)116
TABLE 82EUROPE: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)116
TABLE 83EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)116
TABLE 84EUROPE: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)117
TABLE 85EUROPE: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)117
TABLE 86EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)117
TABLE 87EUROPE: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)118
9.3.1GERMANY118
9.3.1.1The rising number of drug-related deaths in Germany drives
the demand for drug screening products & services118
TABLE 88GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)118
TABLE 89GERMANY: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)119
TABLE 90GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)119
TABLE 91GERMANY: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)119
TABLE 92GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)119
TABLE 93GERMANY: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)120
TABLE 94GERMANY: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)120
TABLE 95GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)120
TABLE 96GERMANY: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)121
9.3.2FRANCE121
9.3.2.1Cannabis and cocaine are the most widely used illicit substances in France121
TABLE 97FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)121
TABLE 98FRANCE: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)122
TABLE 99FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)122
TABLE 100FRANCE: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)122
TABLE 101FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)122
TABLE 102FRANCE: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)123
TABLE 103FRANCE: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)123
TABLE 104FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)123
TABLE 105FRANCE: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)124
9.3.3UK124
9.3.3.1Favorable government support is a key growth driver for the UK market124
TABLE 106UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)125
TABLE 107UK: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)125
TABLE 108UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)125
TABLE 109UK: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)125
TABLE 110UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)126
TABLE 111UK: URINE TESTING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)126
TABLE 112UK: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)126
TABLE 113UK: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)127
TABLE 114UK: DRUG SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)127
9.3.4ITALY127
9.3.4.1Cannabis is the most widely used illicit drug among adolescents
in Italy127
TABLE 115ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)128
TABLE 116ITALY: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)128
TABLE 117ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)128
TABLE 118ITALY: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)129
TABLE 119ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)129
TABLE 120ITALY: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)129
9.3.5SPAIN130
9.3.5.1Cannabis and cocaine are the most widely used drugs in Spain among adolescents and adults130
TABLE 121SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)130
TABLE 122SPAIN: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)131
TABLE 123SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)131
TABLE 124SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)131
TABLE 125SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)132
TABLE 126SPAIN: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)132
9.3.6ROE132
TABLE 127ROE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)133
TABLE 128ROE: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)133
TABLE 129ROE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)134
TABLE 130ROE: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)134
TABLE 131ROE: RAPID TESTING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)134
TABLE 132ROE: URINE TESTING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)134
TABLE 133ROE: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)135
TABLE 134ROE: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)135
TABLE 135ROE: DRUG SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)135
9.4ASIA PACIFIC (APAC)136
FIGURE 23APAC: DRUG SCREENING MARKET SNAPSHOT136
TABLE 136APAC: DRUG SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)137
TABLE 137APAC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)137
TABLE 138APAC: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)137
TABLE 139APAC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)138
TABLE 140APAC: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)138
TABLE 141APAC: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)138
TABLE 142APAC: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)138
TABLE 143APAC: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)139
TABLE 144APAC: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)139
TABLE 145APAC: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)139
9.4.1CHINA140
9.4.1.1China accounted for the largest share of the drug screening market in the APAC region in 2020140
TABLE 146CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)140
TABLE 147CHINA: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)140
TABLE 148CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)141
TABLE 149CHINA: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)141
TABLE 150CHINA: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)141
TABLE 151CHINA: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)141
TABLE 152CHINA: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)142
TABLE 153CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)142
TABLE 154CHINA: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)142
9.4.2JAPAN143
9.4.2.1Stringent laws for drug abuse and the growing awareness of drug addiction are key growth drivers in Japan143
TABLE 155JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)143
TABLE 156JAPAN: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)144
TABLE 157JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)144
TABLE 158JAPAN: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)144
TABLE 159JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)144
TABLE 160JAPAN: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)145
TABLE 161JAPAN: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)145
TABLE 162JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)145
TABLE 163JAPAN: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)146
9.4.3INDIA146
9.4.3.1The increasing burden of DUI-road cases in the country to drive
the growth of the drug screening market146
TABLE 164INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)147
TABLE 165INDIA: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)147
TABLE 166INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)147
TABLE 167INDIA: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)147
TABLE 168INDIA: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)148
TABLE 169INDIA: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)148
TABLE 170INDIA: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)148
TABLE 171INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)149
TABLE 172INDIA: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)149
9.4.4REST OF ASIA PACIFIC (ROAPAC)149
TABLE 173ROAPAC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)150
TABLE 174ROAPAC: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)150
TABLE 175ROAPAC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)151
TABLE 176ROAPAC: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)151
TABLE 177ROAPAC: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)151
TABLE 178ROAPAC: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)151
TABLE 179ROAPAC: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)152
TABLE 180ROAPAC: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)152
TABLE 181ROAPAC: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)152
9.5REST OF THE WORLD (ROW)153
TABLE 182ROW: DRUG SCREENING MARKET, BY REGION, 2019–2026 (USD MILLION)153
TABLE 183ROW: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)153
TABLE 184ROW: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)153
TABLE 185ROW: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)154
TABLE 186ROW: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)154
TABLE 187ROW: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)154
TABLE 188ROW: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)154
TABLE 189ROW: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)155
TABLE 190ROW: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)155
TABLE 191ROW: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)155
9.5.1LATAM156
9.5.1.1Increasing incidence of drug overdose and favorable government support are key growth drivers in this region156
TABLE 192LATAM: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)156
TABLE 193LATAM: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)156
TABLE 194LATAM: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)157
TABLE 195LATAM: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)157
TABLE 196LATAM: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)157
TABLE 197LATAM: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)157
TABLE 198LATAM: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)158
TABLE 199LATAM: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)158
TABLE 200LATAM: DRUG SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION)158
9.5.2MIDDLE EAST & AFRICA159
9.5.2.1Rising drug abuse and growing emphasis on drug abuse testing supports the market growth in the MEA region159
TABLE 201MEA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION)159
TABLE 202MEA: DRUG SCREENING PRODUCT MARKET, BY TYPE,
2019–2026 (USD MILLION)159
TABLE 203MEA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)160
TABLE 204MEA: BREATHALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION)160
TABLE 205MEA: RAPID TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)160
TABLE 206MEA: URINE TESTING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)160
TABLE 207MEA: CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)161
TABLE 208MEA: DRUG SCREENING MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION)161
TABLE 209MEA: DRUG SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)161
10COMPETITIVE LANDSCAPE162
10.1OVERVIEW162
FIGURE 24KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN THE DRUG SCREENING MARKET (2018-2021)162
10.2MARKET RANKING163
FIGURE 25DRUG SCREENING SERVICES MARKET RANKING, BY KEY PLAYER, 2020163
FIGURE 26RAPID TESTING DEVICES MARKET RANKING, BY KEY PLAYER, 2020163
10.3COMPANY EVALUATION QUADRANT165
10.3.1STARS165
10.3.2EMERGING LEADERS165
10.3.3PERVASIVE PLAYERS165
10.3.4PARTICIPANTS165
FIGURE 27DRUG SCREENING MARKET: COMPANY EVALUATION QUADRANT,
2020 (OVERALL MARKET)166
10.4COMPANY EVALUATION QUADRANT FOR EMERGING PLAYERS167
10.4.1PROGRESSIVE COMPANIES167
10.4.2STARTING BLOCKS167
10.4.3RESPONSIVE COMPANIES167
10.4.4DYNAMIC COMPANIES167
FIGURE 28DRUG SCREENING MARKET: COMPANY EVALUATION QUADRANT,
2020 (EMERGING PLAYERS)168
10.5COMPETITIVE BENCHMARKING169
10.5.1OVERALL COMPANY FOOTPRINT169
TABLE 210OVERALL COMPANY FOOTPRINT169
10.5.2COMPANY PRODUCT AND SERVICE FOOTPRINT169
TABLE 211COMPANY PRODUCT AND SERVICE FOOTPRINT169
10.5.3COMPANY PRODUCTS FOOTPRINT170
TABLE 212COMPANY PRODUCT FOOTPRINT170
10.5.4COMPANY REGION FOOTPRINT170
TABLE 213COMPANY REGION FOOTPRINT170
10.6COMPETITIVE SCENARIO171
TABLE 214PRODUCT LAUNCHES & APPROVALS (JANUARY 2018 ─JUNE2021)171
TABLE 215DEALS (JANUARY 2018─AUGUST 2021)172
TABLE 216OTHER DEVELOPMENTS (JANUARY 2018– JUNE 2021)173
11COMPANY PROFILES174
11.1KEY PLAYERS174
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1LABCORP174
TABLE 217LABCORP: BUSINESS OVERVIEW174
FIGURE 29LABCORP: COMPANY SNAPSHOT (2020)175
11.1.2QUEST DIAGNOSTICS177
TABLE 218QUEST DIAGNOSTICS: BUSINESS OVERVIEW177
FIGURE 30QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2020)177
11.1.3ABBOTT LABORATORIES180
TABLE 219ABBOTT LABORATORIES: BUSINESS OVERVIEW180
FIGURE 31ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)181
11.1.4ORASURE TECHNOLOGIES184
TABLE 220ORASURE TECHNOLOGIES: BUSINESS OVERVIEW184
FIGURE 32ORASURE TECHNOLOGIES: COMPANY SNAPSHOTS (2020)185
11.1.5ALFA SCIENTIFIC DESIGNS187
TABLE 221ALFA SCIENTIFIC DESIGNS: BUSINESS OVERVIEW187
11.1.6THERMO FISHER SCIENTIFIC189
TABLE 222THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW189
FIGURE 33THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOTS (2020)190
11.1.7DRÄGERWERK193
TABLE 223DRÄGERWERK: BUSINESS OVERVIEW193
FIGURE 34DRÄGERWERK: COMPANY SNAPSHOT (2020)194
11.1.8LIFELOC TECHNOLOGIES196
TABLE 224LIFELOC TECHNOLOGIES: BUSINESS OVERVIEW196
FIGURE 35LIFELOC: COMPANY SNAPSHOT (2020)196
11.1.9MPD INC.199
TABLE 225MPD INC: BUSINESS OVERVIEW199
11.1.10OMEGA LABORATORIES201
TABLE 226OMEGA LABORATORIES: BUSINESS OVERVIEW201
11.1.11PREMIER BIOTECH202
TABLE 227PREMIER BIOTECH: BUSINESS OVERVIEW202
11.1.12PSYCHEMEDICS203
TABLE 228PSYCHEMEDICS: BUSINESS OVERVIEW203
FIGURE 36PSYCHEMEDICS: COMPANY SNAPSHOT (2020)203
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2OTHER PLAYERS205
11.2.1ROCHE205
11.2.2SHIMADZU206
11.2.3SIEMENS HEALTHINEERS207
11.2.4AMERICAN BIO MEDICA CORPORATION208
11.2.5ACM GLOBAL LABORATORIES209
11.2.6CAREHEALTH AMERICA CORP210
11.2.7CLINICAL REFERENCE LABORATORY211
11.2.8INTOXIMETERS212
11.2.9SCITECK, INC.213
11.2.10ACCUSOURCE214
11.2.11CORDANT HEALTH SOLUTIONS214
11.2.12SYNENS215
11.2.13MILLENNIUM HEALTH215
12APPENDIX216
12.1DISCUSSION GUIDE216
12.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL220
12.3AVAILABLE CUSTOMIZATIONS222
12.4RELATED REPORTS222
12.5AUTHOR DETAILS223


    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com